TITLE

Antidepressant Treatment Strategies in the Perinatal Period with a Focus on SSRI use

AUTHOR(S)
SAATCİOĞLU, Ömer; Buket TOMRUK, Nesrin
PUB. DATE
March 2013
SOURCE
Archives of Neuropsychiatry / Noropsikiatri Arsivi;Mar2013, Vol. 50 Issue 1, p93
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented which is concerned with antidepressant treatment strategies in the perinatal period with a focus on selective serotonin reuptake inhibitors.
ACCESSION #
86417838

 

Related Articles

  • Vortioxetine approved for major depressive disorder.  // WHO Drug Information;2013, Vol. 27 Issue 4, p359 

    The article discusses the U.S. Food and Drug Administration's (FDA) approval of vortioxetine for the treatment of adults with major depressive disorder.

  • Two Drugs Approved for Major Depressive Disorder.  // Journal of Psychosocial Nursing & Mental Health Services;Sep2013, Vol. 51 Issue 9, p6 

    No abstract available.

  • Review: SSRIs and TCAs equally effective at treating chronic depression and dysthemia; SSRIs are associated with fewer adverse events than TCAs. Kocsis, James H // Evidence Based Mental Health;Aug2013, Vol. 16 Issue 3, p82 

    The article presents an abstract of a review of a study by A. von Wolff and colleagues published in a 2013 issue of the "Journal of Affective Disorders" on the effectiveness and tolerability of selective serotonin reuptake inhibitors (SSRIs) compared with tricyclic antidepressants (TCAs) in the...

  • Antidepressants During Pregnancy: Safe? Doheny, Kathleen // Inside Childbirth Education;Jan2013, p7 

    The article presents a study focused on analyzing the effects of consuming antidepressants during pregnancy, published in the periodical "Journal of the American Medical Association," and was conducted by the researchers of the Karolinksa Instutet in Stockholm, Sweden. As mentioned, study was...

  • The Monoamine Oxidase Inhibitors: Relics Reconsidered. O'Brien, Virginia // Psychiatric Annals;Mar2011, Vol. 41 Issue 3, p176 

    The article evaluates the potential of monoamine oxidase inhibitors (MAOIs) in fighting depression. Their mood-improving attributes were found in the 1950s through iproniazid, a drug used in treating tuberculosis and can enhance the emotions of patients, although MAOIs became less popular...

  • Antidepressants: From MAOIs to SSRIs and more. Ramachandraih, Chaitra T.; Subramanyam, Narayana; Bar, Kral Jurgen; Baker, Glen; Yeragani, Vikram K. // Indian Journal of Psychiatry;Apr-Jun2011, Vol. 53 Issue 2, p180 

    The article presents information related to the development of antidepressants. The mood elevating property of isoniazid became the primary effect in depression and started generations of newer antidepressants. Currently, monoamine oxidase (MAO) inhibitors are not first choice antidepressants...

  • Consider behavioural strategies in addition to antidepressants in clinically depressed patients with chronic obstructive pulmonary disease.  // Drugs & Therapy Perspectives;Feb2015, Vol. 31 Issue 2, p52 

    Depression is common in older patients with chronic obstructive pulmonary disease. However, evidence clearly establishing the effectiveness of specific antidepressants in inducing remission of depression and/or improving dyspnoea and physiological measures in this patient population is lacking....

  • L-METHYLFOLATE EFFECTIVE IN THE TREATMENT OF A MDD. C. D. N. // Primary Psychiatry;Jul2010, Vol. 17 Issue 7, p21 

    The article discusses research by Lawrence D. Ginsberg and colleagues on the efficacy of L-Methylfolate in the treatment of a major depressive disorder (MDD). The researchers studied patients with a primary diagnosis of MDD with a single or recurrent major depressive episode (MDE). They...

  • Most adolescents achieve longer term remission from major depressive disorder regardless of type of short-term second-line treatment. Michael, Kurt D. // Evidence Based Mental Health;Aug2011, Vol. 14 Issue 3, p85 

    The author comments on a study by B. Vitiello and colleagues about the long-term outcomes for adolescents with major depressive disorder (MDD) who are resistant to selective serotonin reuptake inhibitor (SSRI) treatment. The study found that most of SSRI-resistant adolescents who received...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics